201. Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei
- Author
-
Yo Kawaguchi and Jun Hanaoka
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Poor prognosis ,Mitomycin ,medicine.medical_treatment ,Antineoplastic Agents ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Pseudomyxoma peritonei ,Chemotherapy ,Thoracic cavity ,business.industry ,Cytoreduction Surgical Procedures ,Hyperthermia, Induced ,Middle Aged ,Pseudomyxoma Peritonei ,medicine.disease ,Diaphragm (structural system) ,medicine.anatomical_structure ,030228 respiratory system ,Chemotherapy, Adjuvant ,Surgery ,Good prognosis ,Radiology ,Cardiology and Cardiovascular Medicine ,Cytoreductive surgery ,business ,Pleurectomy - Abstract
Dissemination of pseudomyxoma peritonei into the thoracic cavity is rare and carries a poor prognosis. Optimal treatment has not been defined. In our institution, patients have received cytoreductive surgery with hyperthermic intrathoracic chemotherapy, which demonstrated a good prognosis. A 51-year-old woman was referred to our hospital with right intrathoracic dissemination of pseudomyxoma peritonei. We performed parietal and mediastinal pleurectomy and simple resection of all visible tumors on the diaphragm and visceral pleura, followed by hyperthermic intrathoracic chemotherapy with 20 mg mitomycin at 42°C to 43°C. The patient had no evidence of disease progression in the thoracic cavity 1 year after surgery.
- Published
- 2020